Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Suspended No phase listed Observational

INSPIRIS RESILIA Aortic Valve, Valve-in-Valve Surveillance Study

ClinicalTrials.gov ID: NCT04902053

Public ClinicalTrials.gov record NCT04902053. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 16, 2026, 2:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of the INSPIRIS RESILIA Aortic Valve-in-valve (ViV) Surveillance Study ("the Study") is to capture Adverse Event information and valve measurement data from dysfunctional INSPIRIS RESILIA aortic valves before and after Valve-in-valve (ViV) treatment.

Study identification

NCT ID
NCT04902053
Recruitment status
Suspended
Study type
Observational
Phase
Not listed
Lead sponsor
Edwards Lifesciences
Industry
Enrollment
50 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2028
Primary completion
Nov 30, 2030
Completion
Dec 31, 2030
Last update posted
Aug 3, 2026

2028 – 2031

United States locations

U.S. sites
7
U.S. states
6
U.S. cities
7
Facility City State ZIP Site status
University of Southern California Los Angeles California 90033
University of Florida Gainesville Florida 32611
AdventHealth Orlando Orlando Florida 32803
St. Vincent Hospital Indianapolis Indiana 46290
Nyph/Cumc New York New York 10032
The Cleveland Clinic Foundation Cleveland Ohio 44195
University of Pennsylvania Philadelphia Pennsylvania 19104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04902053, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 3, 2026 · Synced Sep 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04902053 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →